23andMe's Designer Baby Patent
By Dov Fox,
Huffington Post
| 10. 04. 2013
The U.S. Patent and Trademark Office (PTO) this week awarded a patent on "gamete donor selection" to 23andMe, the genetic testing company that sells at-home DNA kits directly to consumers. Patent #8,543,339 grants 23andMe exclusive rights to genetic and computer technologies that would enable prospective parents to handpick a sperm or egg donor with whom they would be likely to produce a child born with certain traits that they desire.
It's not just couples already planning to have a baby together who can use the patented technology to learn the likelihood that their child will inherit certain "phenotypes of interest in the hypothetical offspring." The patent also covers genetic selection from among a broader menu of options by predicting how a person's DNA would combine with any number of available donors to produce a child of a particular type. The patent illustrates:
There's much to be said for 23andMe's mission to empower people with genetic information about themselves and their potential children. What mother or father doesn't want to give his or her child the best chance of leading a...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...